Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment

Advances in cancer immunity have promoted a major breakthrough in the field of cancer therapy. This is mainly associated with the successful development of immune checkpoint inhibitors (ICIs) for multiple types of human tumors. Blockade with different ICIs, including programmed cell death 1 (PD-1),...

Full description

Bibliographic Details
Main Authors: Yuxiao Song, Yang Fu, Qi Xie, Bo Zhu, Jun Wang, Bicheng Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitor
PD-1
PD-L1
anti-angiogenesis
tumor microenvironment
combination therapy
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01956/full

Similar Items

Similar Items